Your browser doesn't support javascript.
loading
Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis.
Zhang, Yunfei; Huang, Ping; Liu, Xuewen; Xiang, Yuchen; Zhang, Te; Wu, Yezi; Xu, Jiaxin; Sun, Zhiting; Zhen, Weiguo; Zhang, Liang; Si, Yuan; Liu, Ying.
Afiliação
  • Zhang Y; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Huang P; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Liu X; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Xiang Y; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Zhang T; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Wu Y; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Xu J; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Sun Z; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Zhen W; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Zhang L; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China; Biomedical Research Institute, Hubei University of Medicine, Shiyan, Hubei, 442000, China.
  • Si Y; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China; Biomedical Research Institute, Hubei University of Medicine, Shiyan, Hubei, 442000, China. Electronic address: siyuan138@126.com.
  • Liu Y; Laboratory of Molecular Target Therapy of Cancer, Institute of Basic Medical Sciences, Hubei University of Medicine, Shiyan, Hubei, 442000, China; Biomedical Research Institute, Hubei University of Medicine, Shiyan, Hubei, 442000, China. Electronic address: ying_liu1002@163.com.
J Pharmacol Sci ; 137(3): 305-312, 2018 Jul.
Article em En | MEDLINE | ID: mdl-30119963
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Autoantígenos / Neoplasias Gástricas / Transdução de Sinais / Cisplatino / Proliferação de Células / Diosgenina / Proteínas Proto-Oncogênicas c-akt / Proteína Fosfatase 2 / Transição Epitelial-Mesenquimal / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pharmacol Sci Assunto da revista: FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Autoantígenos / Neoplasias Gástricas / Transdução de Sinais / Cisplatino / Proliferação de Células / Diosgenina / Proteínas Proto-Oncogênicas c-akt / Proteína Fosfatase 2 / Transição Epitelial-Mesenquimal / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pharmacol Sci Assunto da revista: FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China